CELEX: 62020TN0706
Language: en
Date: 2020-11-30 00:00:00
Title: Case T-706/20: Action brought on 30 November 2020 — MiMedx Group v EUIPO — DIZG (Epiflex)

1.2.2021   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 35/55
            
         
      Action brought on 30 November 2020 — MiMedx Group v EUIPO — DIZG (Epiflex)
      (Case T-706/20)
      (2021/C 35/73)
      Language of the case: English
      
         Parties
      
      
         Applicant: MiMedx Group, Inc. (Marietta, Georgia, United States) (represented by: J. Bogatz and Y. Stone, lawyers)
      
         Defendant: European Union Intellectual Property Office (EUIPO)
      
         Other party to the proceedings before the Board of Appeal: DIZG Deutsches Institut für Zell- und Gewebeersatz gGmbH (Berlin, Germany)
      
         Details of the proceedings before EUIPO
      
      
         Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
      
         Trade mark at issue: European Union word mark Epiflex — European Union trade mark No 1 281 385
      
         Procedure before EUIPO: Cancellation proceedings
      
         Contested decision: Decision of the Second Board of Appeal of EUIPO of 25 September 2020 in Case R 133/2020-2
      
         Form of order sought
      
      The applicant claims that the Court should:
      
                  —
               
               
                  annul the contested decision
               
            
                  —
               
               
                  order EUIPO and the other Party to the proceedings to pay the costs incurred by the applicant.
               
            
         Pleas in law
      
      
                  —
               
               
                  Infringement of Article 58 of Regulation (EU) 2017/1001 of the European Parliament and of the Council in conjunction with Article 19(1) of Commission Delegated Regulation (EU) 2017/1430;
               
            
                  —
               
               
                  Infringement of the principle of equality as laid down in Article 20 in conjunction with Article 41 of the Charter of Fundamental Rights of the European Union (‘the Charter’);
               
            
                  —
               
               
                  Infringement of the right to good administration as laid down in Article 41(1) of the Charter;
               
            
                  —
               
               
                  Infringement of right to a fair trial as laid down in Article 47 of the Charter;
               
            
                  —
               
               
                  Infringement of Article 95(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in conjunction with Articles 19(1), third sentence, and 10(7) of Commission Delegated Regulation (EU) 2017/1430.